Six-Month Results of the World's First VASC Clinical Trial for Endovascular NTNT Treatment of GSV Through Empty Vein Ablation Using Velex ™

To report six-month results from the VASC (Vacuum Assisted Sclerotherapy Catheter) study, a multicentric, prospective, non-randomized trial with the primary objective to confirm safety and efficacy of Velex for empty vein ablation (EVA) of the great saphenous vein (GSV; ClinicalTrials.gov, NCT05581524).
Source: Journal of Vascular Surgery - Category: Surgery Authors: Source Type: research